Your browser doesn't support javascript.
loading
Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study.
Ruel, Theodore D; Capparelli, Edmund V; Tierney, Camlin; Nelson, Bryan S; Coletti, Anne; Bryson, Yvonne; Cotton, Mark F; Spector, Stephen A; Mirochnick, Mark; LeBlanc, Rebecca; Reding, Christina; Zimmer, Bonnie; Persaud, Deborah; Bwakura-Dangarembizi, Mutsa; Naidoo, Kimesh L; Hazra, Rohan; Jean-Philippe, Patrick; Chadwick, Ellen G.
Afiliação
  • Ruel TD; University of California San Francisco, San Francisco, CA, USA. Electronic address: theodore.ruel@ucsf.edu.
  • Capparelli EV; University of California San Diego, La Jolla, CA, USA.
  • Tierney C; Harvard TH Chan School of Public Health, Boston, MA, USA.
  • Nelson BS; Harvard TH Chan School of Public Health, Boston, MA, USA.
  • Coletti A; FHI 360, Durham, NC, USA.
  • Bryson Y; University of Los Angeles, Los Angeles, CA, USA.
  • Cotton MF; Stellenbosch University, Tygerberg, South Africa.
  • Spector SA; University of California San Diego, La Jolla, CA, USA.
  • Mirochnick M; Boston University School of Medicine, Boston, MA, USA.
  • LeBlanc R; Frontier Science and Technology Research Foundation, Amherst, NY, USA.
  • Reding C; Frontier Science and Technology Research Foundation, Amherst, NY, USA.
  • Zimmer B; Frontier Science and Technology Research Foundation, Amherst, NY, USA.
  • Persaud D; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Bwakura-Dangarembizi M; University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.
  • Naidoo KL; Nelson R Mandela School of Medicine, Durban, South Africa.
  • Hazra R; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
  • Jean-Philippe P; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Chadwick EG; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Lancet HIV ; 8(3): e149-e157, 2021 03.
Article em En | MEDLINE | ID: mdl-33242457
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Inibidores da Transcriptase Reversa / Fármacos Anti-HIV / Nevirapina Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male / Newborn / Pregnancy Idioma: En Revista: Lancet HIV Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Inibidores da Transcriptase Reversa / Fármacos Anti-HIV / Nevirapina Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Infant / Male / Newborn / Pregnancy Idioma: En Revista: Lancet HIV Ano de publicação: 2021 Tipo de documento: Article